BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21346230)

  • 21. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.
    Knight JS; Luo W; O'Dell AA; Yalavarthi S; Zhao W; Subramanian V; Guo C; Grenn RC; Thompson PR; Eitzman DT; Kaplan MJ
    Circ Res; 2014 Mar; 114(6):947-56. PubMed ID: 24425713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
    Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
    Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citrullinated proteins in rheumatoid arthritis.
    Yamada R; Suzuki A; Chang X; Yamamoto K
    Front Biosci; 2005 Jan; 10():54-64. PubMed ID: 15574347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic administration of Cl-amidine, a pan-peptidylarginine deiminase inhibitor, does not reverse bone loss in two different murine models of osteoporosis.
    Vargas-Muñoz VM; Martínez-Martínez A; Muñoz-Islas E; Ramírez-Rosas MB; Acosta-González RI; Jiménez-Andrade JM
    Drug Dev Res; 2020 Feb; 81(1):93-101. PubMed ID: 31633211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
    Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
    Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
    Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
    Front Immunol; 2021; 12():716250. PubMed ID: 34737738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
    Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
    Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophils cast NETs in atherosclerosis: employing peptidylarginine deiminase as a therapeutic target.
    Döring Y; Soehnlein O; Weber C
    Circ Res; 2014 Mar; 114(6):931-4. PubMed ID: 24625721
    [No Abstract]   [Full Text] [Related]  

  • 29. Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis.
    Makrygiannakis D; Revu S; Engström M; af Klint E; Nicholas AP; Pruijn GJ; Catrina AI
    Arthritis Res Ther; 2012 Jan; 14(1):R20. PubMed ID: 22284820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Rac1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis.
    Abreu JR; Dontje W; Krausz S; de Launay D; van Hennik PB; van Stalborch AM; Ten Klooster JP; Sanders ME; Reedquist KA; Vervoordeldonk MJ; Hordijk PL; Tak PP
    Arthritis Res Ther; 2010; 12(1):R2. PubMed ID: 20053277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin B12 inhibits peptidylarginine deiminases and ameliorates rheumatoid arthritis in CAIA mice.
    Yang CW; Hsu HY; Lee YZ; Lee SJ
    Biochem Biophys Res Commun; 2024 Apr; 704():149668. PubMed ID: 38401303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of the cholinergic anti-inflammatory pathway on collagen-induced arthritis involves the modulation of dendritic cell differentiation.
    Liu D; Li T; Luo H; Zuo X; Liu S; Wu S
    Arthritis Res Ther; 2018 Nov; 20(1):263. PubMed ID: 30486874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anomalies of intra-synovial citrullination: is there any interest in the diagnosis of early rheumatoid arthritis?
    Mrabet D; Laadhar L; Haouet S; Sahli H; Zouari B; Makni S; Sellami S
    Rheumatol Int; 2013 Mar; 33(3):787-91. PubMed ID: 22083618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
    J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
    Shen Y; You Q; Wu Y; Wu J
    Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.
    Moon DO; Kim MO; Choi YH; Park YM; Kim GY
    Int Immunopharmacol; 2010 May; 10(5):605-10. PubMed ID: 20188213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.
    Witalison EE; Thompson PR; Hofseth LJ
    Curr Drug Targets; 2015; 16(7):700-10. PubMed ID: 25642720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmunity to citrullinated type II collagen in rheumatoid arthritis.
    Yoshida M; Tsuji M; Kurosaka D; Kurosaka D; Yasuda J; Ito Y; Nishizawa T; Yamada A
    Mod Rheumatol; 2006; 16(5):276-81. PubMed ID: 17039307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritis.
    Boyle DL; Kim HR; Topolewski K; Bartok B; Firestein GS
    J Pharmacol Exp Ther; 2014 Feb; 348(2):271-80. PubMed ID: 24244039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice.
    Sodré FMC; Bissenova S; Bruggeman Y; Tilvawala R; Cook DP; Berthault C; Mondal S; Callebaut A; You S; Scharfmann R; Mallone R; Thompson PR; Mathieu C; Buitinga M; Overbergh L
    Diabetes; 2021 Feb; 70(2):516-528. PubMed ID: 33203696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.